Mesenchymal Stem Cell-Derived Exosomes for Myocardial Infarction Treatment
Myocardial infarction (MI) is a major cause of morbidity and mortality in modern society. Over the past decades, mesenchymal stem cell (MSCs)-based therapy has shown promising results in the treatment of MI due to their unique properties of multi-differentiation ability, immune-privileged phenotype...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2023
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/86691 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Mesenchymal Stem Cell-Derived Exosomes for Myocardial Infarction Treatment
- Mesenchymal Stem Cell-Derived Exosomes as a New Possible Therapeutic Strategy for Parkinson’s Disease
- Derivation of Mesenchymal Stem Cells from Human Embryonic Stem Cells
- Emerging Role and Therapeutic Application of Mesenchymal Stem Cell (MSC) and MSC-Derived Exosome in Coronavirus Disease-2019 (COVID-19) Infection
- Harnessing the Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in Prostate Cancer: Current Insight and Perspective
- Potentiality of Very Small Embryonic-Like Stem Cells to Repair Myocardial Infarction
- Stem Cell Therapy in Myocardial Infarction Clinical Point of View and the Results of the REANIMA Study (REgenerAtion of Myocardium with boNe Marrow Mononuclear Cells in MyocArdial Infarction)